Literature DB >> 10199467

Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors.

K Sircar1, B R Hewlett, J D Huizinga, K Chorneyko, I Berezin, R H Riddell.   

Abstract

Interstitial cells of Cajal (ICC) are implicated in the regulation of gut peristalsis and are immunostained by antibodies against Kit (CD117), a tyrosine kinase receptor. Most gastrointestinal mesenchymal tumors (GIMTs) are of uncertain histogenesis, although many are CD34-positive. CD34 was found to colocalize with vimentin (Vim) and the Kit-positive networks of cells within and around neural plexi, indicating that ICC can be Vim- and CD34-positive. ICCs appear to be the only Kit+CD34+Vim+ cell in the gut. Formalin-fixed, paraffin-embedded tissues from 43 GIMTs were immunostained for Kit, CD34, Vim, PGP 9.5 (PGP, a neural marker), muscle-specific actin (MSA), and other markers including desmin (Des). Eight tumors were myoid (MSA+Des+Vim-Kit-CD34-), and one was a schwannoma (PGP+S100+Vim+Kit-CD34-), but 34 tumors were of uncertain histogenesis (gastrointestinal stromal tumors, GIST), exhibiting neither a complete myoid nor a schwannian immunophenotype. All 34 were Vim+, and 33/34 were either Kit (n = 30) or CD34 (n = 23) immunoreactive. Of these 34 GIST, 24 were negative for all myoid and neural markers, 6 were PGP+S100-, and 4 were MSA+Des-. The Kit+CD34+Vim+ immunophenotype of GIST suggests that they originate from, or have differentiated into, ICC-like cells; the term ICC tumor (ICCT) is suggested. Kit is a more sensitive marker than CD34 for ICCT, but both are required in tumor identification. All clinically malignant GISTs were pathologically malignant (size, mitoses) but also showed loss of either CD34 or Kit. "Blind" examination of electron micrographs in 10 tumors showed them to be heterogeneous. Some had features seen in normal ICC, but cells could not be positively identified as being adult ICC. GIMT may therefore be classifiable into those with pure myoid, schwannian (or neural) differentiation, but the majority are of ICC origin or show ICC differentiation immunophenotypically (ICCT).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199467     DOI: 10.1097/00000478-199904000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  126 in total

1.  Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal.

Authors:  T Tsujimura; C Makiishi-Shimobayashi; J Lundkvist; U Lendahl; K Nakasho; A Sugihara; T Iwasaki; M Mano; N Yamada; K Yamashita; A Toyosaka; N Terada
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 2.  Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.

Authors:  Shelby D Melton; Robert M Genta; Rhonda F Souza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

3.  A rare case of huge gastrointestinal stromal tumor (GIST) of the stomach extending into the posterior mediastinum.

Authors:  Hideki Machishi; Yoshikatsu Okada; Moritaka Nagai; Naoya Noda; Tomohide Hori; Takashi Shimono; Toshio Fukudome
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

4.  Endoscopic ultrasound-guided Trucut biopsy of gastrointestinal mesenchymal tumor.

Authors:  John DeWitt; Robert E Emerson; Stuart Sherman; Mohammad Al-Haddad; Lee McHenry; Gregory A Cote; Julia K Leblanc
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

5.  Sporadic Cajal cell hyperplasia is common in resection specimens for distal oesophageal carcinoma. A retrospective review of 77 consecutive surgical resection specimens.

Authors:  Abbas Agaimy; Peter H Wünsch
Journal:  Virchows Arch       Date:  2005-11-25       Impact factor: 4.064

6.  Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas.

Authors:  Toshiyuki Nakayama; Ayumi Yoshizaki; Shinji Naito; Chun-Yang Wen; Gabit Alipov; Yuichi Yakata; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors.

Authors:  Erik Berglund; David Berglund; Pinar Akcakaya; Mehran Ghaderi; Elisabetta Daré; Per-Olof Berggren; Martin Köhler; Craig A Aspinwall; Weng-Onn Lui; Jan Zedenius; Catharina Larsson; Robert Bränström
Journal:  Exp Cell Res       Date:  2013-03-13       Impact factor: 3.905

8.  Clinicopathological study of 113 gastrointestinal stromal tumors.

Authors:  Rahul Bhalgami; Kak Manish; Prachi Patil; Shaesta Mehta; K M Mohandas
Journal:  Indian J Gastroenterol       Date:  2012-12-08

9.  Colorectal gastrointestinal stromal tumors: a brief review.

Authors:  Rishindra M Reddy; James W Fleshman
Journal:  Clin Colon Rectal Surg       Date:  2006-05

10.  [Gastrointestinal stromal tumor of the abdominal wall. An unusual localization of a rare tumor].

Authors:  A Thalheimer; D Meyer; S Gattenlöhner; W Timmermann; A Thiede
Journal:  Chirurg       Date:  2004-07       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.